 Sensitivity and Specificity
"Sensitivity and Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Descriptor ID |
D012680
|
| MeSH Number(s) |
E05.318.740.872 E05.318.780.800 G17.800 N05.715.360.750.725 N05.715.360.780.700 N06.850.520.445.800 N06.850.520.830.872
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sensitivity and Specificity".
Below are MeSH descriptors whose meaning is more specific than "Sensitivity and Specificity".
This graph shows the total number of publications written about "Sensitivity and Specificity" by people in this website by year, and whether "Sensitivity and Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 4 | 4 | | 1993 | 0 | 3 | 3 | | 1995 | 0 | 3 | 3 | | 1996 | 0 | 7 | 7 | | 1997 | 0 | 8 | 8 | | 1998 | 0 | 6 | 6 | | 1999 | 0 | 9 | 9 | | 2000 | 0 | 10 | 10 | | 2001 | 0 | 5 | 5 | | 2002 | 0 | 21 | 21 | | 2003 | 0 | 18 | 18 | | 2004 | 0 | 17 | 17 | | 2005 | 0 | 30 | 30 | | 2006 | 0 | 30 | 30 | | 2007 | 0 | 20 | 20 | | 2008 | 0 | 30 | 30 | | 2009 | 0 | 21 | 21 | | 2010 | 0 | 18 | 18 | | 2011 | 0 | 22 | 22 | | 2012 | 0 | 24 | 24 | | 2013 | 0 | 24 | 24 | | 2014 | 0 | 17 | 17 | | 2015 | 0 | 24 | 24 | | 2016 | 0 | 22 | 22 | | 2017 | 0 | 13 | 13 | | 2018 | 0 | 21 | 21 | | 2019 | 0 | 12 | 12 | | 2020 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Sensitivity and Specificity" by people in Profiles.
-
AlDubayan SH, Conway JR, Camp SY, Witkowski L, Kofman E, Reardon B, Han S, Moore N, Elmarakeby H, Salari K, Choudhry H, Al-Rubaish AM, Al-Sulaiman AA, Al-Ali AK, Taylor-Weiner A, Van Allen EM. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma. JAMA. 2020 11 17; 324(19):1957-1969.
-
Moore NM, Li H, Schejbal D, Lindsley J, Hayden MK. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2. J Clin Microbiol. 2020 07 23; 58(8).
-
Hu D, Lin H, Zeng X, Wang T, Deng J, Su X. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma. World J Surg. 2020 05; 44(5):1498-1505.
-
Li J, Zhang B, Liu WX, Lu K, Pan H, Wang T, Oh CD, Yi D, Huang J, Zhao L, Ning G, Xing C, Xiao G, Liu-Bryan R, Feng S, Chen D. Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann Rheum Dis. 2020 05; 79(5):635-645.
-
Sidhu R, Kell P, Dietzen DJ, Farhat NY, Do AND, Porter FD, Berry-Kravis E, Vite CH, Reunert J, Marquardt T, Giugliani R, Lourenço CM, Bodamer O, Wang RY, Plummer E, Schaffer JE, Ory DS, Jiang X. Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease. Mol Genet Metab. 2020 04; 129(4):292-302.
-
Swanson B, Fogg L, Julion W, Arrieta MT. Electronic Nose Analysis of Exhaled Breath Volatiles to Identify Lung Cancer Cases: A Systematic Review. J Assoc Nurses AIDS Care. 2020 Jan-Feb; 31(1):71-79.
-
Zhou LQ, Wu XL, Huang SY, Wu GG, Ye HR, Wei Q, Bao LY, Deng YB, Li XR, Cui XW, Dietrich CF. Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning. Radiology. 2020 01; 294(1):19-28.
-
To D, Sharma B, Karnik N, Joyce C, Dligach D, Afshar M. Validation of an alcohol misuse classifier in hospitalized patients. Alcohol. 2020 05; 84:49-55.
-
Charidimou A, Frosch MP, Al-Shahi Salman R, Baron JC, Cordonnier C, Hernandez-Guillamon M, Linn J, Raposo N, Rodrigues M, Romero JR, Schneider JA, Schreiber S, Smith EE, van Buchem MA, Viswanathan A, Wollenweber FA, Werring DJ, Greenberg SM. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int J Stroke. 2019 12; 14(9):956-971.
-
Siddiqi OK, Birbeck GL, Ghebremichael M, Mubanga E, Love S, Buback C, Kosloff B, Ayles H, Atadzhanov M, Dheda K, Koralnik IJ. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia. J Clin Microbiol. 2019 08; 57(8).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|